Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | HBB | P68871 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.30 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4846610 | 0.73 | TP53 (0.37) | TP53HBBSMN1; SMN2BRD4GRIN2B | |
| SCHEMBL28113341 | 0.72 | CYP1A2 (0.46) | TP53HBBSMN1; SMN2BRD4GRIN2B | |
| SCHEMBL8855488 | 0.71 | KMT2A (0.47) | TP53HBBSMN1; SMN2BRD4GRIN2B | |
| SCHEMBL1614716 | 0.71 | KMT2A (0.47) | TP53HBBSMN1; SMN2BRD4GRIN2B | |
| SCHEMBL23458283 | 0.71 | FGFR1 (0.35) | TP53HBBSMN1; SMN2BRD4GRIN2B | |
| SCHEMBL8897393 | 0.71 | KMT2A (0.47) | TP53HBBSMN1; SMN2BRD4GRIN2B | |
| SCHEMBL12231940 | 0.71 | — | — | |
| SCHEMBL22057392 | 0.71 | — | — | |
| SCHEMBL27474143 | 0.67 | GRIN2B (0.45) | BRD4GRIN2BMAPK14CYP1A2CYP3A4 | |
| SCHEMBL11060443 | 0.66 | TP53 (0.60) | TP53HBBSMN1; SMN2GRIN2BDHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7847092-B2 | Method for preparation of F-18 containing organofluoro compounds in alcohol solvents | FUTURECHEM CO., LTD. (KR) | 2010-12-07 | — | — | US | disclosed |
| US-20100113763-A1 | METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS | FUTURECHEM CO., LTD. (KR) | 2010-05-06 | — | — | US | disclosed |
| US-20080171863-A1 | Method for Preparing of Organofluoro Compounds in Alcohol Solvents | FUTURECHEM CO., LTD. (KR) | 2008-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171863-A1 | Method for Preparing of Organofluoro Compounds in Alcohol Solvents | ADH5, ADH1C, ADH1A | TP53 2076/4885HBB 2583/4885SMN1; SMN2 4202/4885 |
| US-20100113763-A1 | METHOD FOR PREPARATION OF ORGANOFLUORO COMPOUNDS IN ALCOHOL SOLVENTS | AFF1, AFF4, PFAS | TP53 2997/4885HBB 570/4885SMN1; SMN2 3759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.